CVS Health (NYSE: CVS) announced today that the opioid overdose-reversal medication naloxone is now available without a prescription at CVS Pharmacy locations in Idaho. Under prescriptive authority allowed by the state, CVS Pharmacists will expand access to the medication. “Naloxone is a safe and effective antidote to opioid overdoses and we can help save lives…
Majority Of Americans Would Consider Participating In An Alzheimer’s Clinical Trial
WASHINGTON /PRNewswire/ — In a first-ever poll conducted online by Harris Poll on behalf of the Global Alzheimer’s Platform (GAP) Foundation, nearly 60 percent of Americans report they are definitely willing or would consider participating in Alzheimer’s disease clinical trials, but participation rates show that less than 10 percent are actually doing so. The failure…
Plinabulin Combination Study Granted FDA Clearance To Enroll Patients
NEW YORK /PRNewswire/ — BeyondSpring Pharmaceuticals, a clinical stage biopharmaceutical company focused on the development of innovative cancer therapies, including a Phase III immuno-oncology compound, Plinabulin, and strong pipeline in collaboration with the Fred Hutchinson Cancer Research Center, has announced that on June 20, 2016, the U.S. FDA notified Dr. Lyudmila Bazhenova at the UC…
Amgen And Daiichi Sankyo To Commercialize Biosimilars In Japan
THOUSAND OAKS, Calif. and TOKYO /PRNewswire/ — Amgen and Daiichi Sankyo Company, Limited have announced the execution of an exclusive agreement to commercialize nine biosimilars in Japan. The deal includes several biosimilars in late-stage development, including biosimilars of adalimumab, bevacizumab and trastuzumab. Under the terms of the agreement, Amgen will remain responsible for the development…
Evelo And Epiva Merge To Create Immuno-Microbiome Platform Company
CAMBRIDGE, Mass. /PRNewswire/ — Flagship Ventures has announced the merger of its portfolio companies Evelo Biosciences and Epiva Biosciences to create the leading immuno-microbiome company, developing therapeutics for cancer, autoimmune and inflammatory diseases. The new entity will keep the name Evelo Biosciences and operate under the leadership of CEO and President, Simba Gill, Ph.D. Noubar…
FDA Approves Single Monthly Injection For A PCSK9 Inhibitor
THOUSAND OAKS, Calif. — Amgen has announced that the U.S. Food and Drug Administration (FDA) has approved the Repatha (evolocumab) PushtronexT system (on-body infusor with prefilled cartridge), a new, monthly single-dose administration option. The Pushtronex system is a hands-free device designed to provide 420 mg of Repatha in a single dose. Repatha is a human…
BioLife Solutions Executes 10 Year Supply Agreement With Kite Pharma
BOTHELL, Wash. /PRNewswire/ — BioLife Solutions, Inc., a developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media and a related cloud hosted biologistics cold chain management app for smart shippers (“BioLife” or the “Company”), has announced that it has entered into a ten year supply agreement with…